FOA, PAOLO

FOA, PAOLO  

Dipartimento di Oncologia ed Emato-Oncologia  

Risultati 1 - 20 di 95 (tempo di esecuzione: 0.003 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
1,25-DIHYDROXYVITAMIN-D3 AND MYELOPROLIFERATIVE SYNDROMES 1-gen-1990 P. FOA + Article (author) -
1,25-DIHYDROXYVITAMIN-D3 IN THE TREATMENT OF IDIOPATHIC THROMBOCYTHEMIA AND MYELOFIBROSIS 1-gen-1990 P. FOA + Article (author) -
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma 1-gen-2013 P. FoaN. Personeni + Article (author) -
A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer 1-mar-2009 J. FioreC. CodecàG. Di MariaBOZZONI, SAMUELAA. LucianiS. ZonatoP. Foa + Article (author) -
Adjuvant chemotherapy in complete resected gastric cancer: evaluation in double left arrow 60 vs > 60 years pts 1-gen-1998 P. Foa + Article (author) -
Adjuvant chemotherapy in completely resected gastric cancer : a randomized phase III trial conducted by GOIRC 19-mar-2008 P. Foa + Article (author) -
Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial 18-apr-2007 P. Foa + Article (author) -
Anti-epidermal growth factor receptor skin toxicity : a matter of topical hydration 1-gen-2016 C. CodecàBOCCI, BARBARAF. CrepaldiM. ViolatiVIALE, GIULIAA. LucianiZONATO, SABRINAG. CassinelliP. Foa + Article (author) -
ANTIBIOTICS FOR DERMATITIS INDUCED BY CETUXIMAB AND CONCOMITANT RADIOTHERAPY 1-gen-2009 P. Foa + Article (author) -
Antiproliferative activity of cyclosporin A on human T-lymphoblastic leukaemia cell line 1-gen-1981 P. FoaL. Baldini + Article (author) -
AUTOIMMUNE HEMOLYTIC-ANEMIA IN A PATIENT WITH IDIOPATHIC HYPEREOSINOPHILIA 1-gen-1995 P. FOA + Article (author) -
BIOLOGICAL CHARACTERIZATION OF REFRACTORY-ANEMIA WITH EXCESS OF BLASTS 1-gen-1987 P. FOAL. BALDINIA. LAVEZZI + Article (author) -
Biological determinants of long-term survival in chronic myelogenous leukemia patients treated with conventional chemotherapy 1-gen-1997 P. Foa + Article (author) -
BIOMOLECULAR MARKERS IN TONGUE CANCER 1-gen-2009 S. BosariP. Foa + Article (author) -
BONE-MARROW BIOPSY IN CHRONIC MYELOID-LEUKEMIA - SIGNIFICANCE OF SOME HISTOLOGICAL PARAMETERS 1-gen-1986 P. FOA + Article (author) -
CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING RADIATION-THERAPY FOR TESTICULAR SEMINOMA 1-gen-1989 P. FOA + Article (author) -
Chronic myeloid leukemia treated with busulfan: Relationship between total amount of drug required during the first year of treatment and duration of chronic phase 1-gen-1996 P. Foa + Article (author) -
Chronic neutrophilc leukaemia associated with polycythemia vera: pathogenetic implications and therapeutic approach 1-gen-1991 P. FoaF. CapsoniA.T. Maiolo + Article (author) -
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial 1-lug-2013 L. LicitraP. Foa + Article (author) -
Clinical analysis of multiple primary malignancies in the elderly 1-gen-2009 A. LucianiG. AscioneD. MarussiC. CodecàS. ZonatoD. FerrariP. Foa + Article (author) -